Form 4: TG Therapeutics Director Sells Shares to Cover Tax Obligations

Laurence N. Charney, a director of TG Therapeutics, sold 22,000 shares of common stock on March 12, 2024, to cover income tax obligations.

Summary

• On March 12, 2024, Laurence N. Charney, a director of TG Therapeutics, sold 22,000 shares of the company's common stock.
• The sale was executed at a weighted average price of $15.97 per share, with prices ranging from $15.95 to $16.00.
• The transaction was conducted by the company's restricted stock administrator to satisfy Mr. Charney's income tax obligations.
• Following the transaction, Mr. Charney beneficially owns 215,229 shares of TG Therapeutics, including restricted common stock that vests over various time periods.

Sentiment

Score: 5

Explanation: The document is a standard SEC Form 4 filing, indicating a routine transaction. The sentiment is neutral as it reflects a director selling shares to cover tax obligations, which is a common practice.

Industry Context

Sales of shares by company directors are a common occurrence, often related to personal financial planning or tax obligations. The market typically views these sales in the context of the director's overall holdings and the reasons behind the sale.

Stakeholder Impact

• The sale of shares by a director could have a minor impact on shareholder sentiment, but is unlikely to have a significant impact given the reason for the sale and the relatively small number of shares involved.

Key Dates